Raymond James & Associates’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-4,825
| Closed | -$329K | – | 4088 |
|
2021
Q2 | $329K | Sell |
4,825
-4,671
| -49% | -$318K | ﹤0.01% | 3353 |
|
2021
Q1 | $659K | Buy |
9,496
+891
| +10% | +$61.8K | ﹤0.01% | 2796 |
|
2020
Q4 | $661K | Sell |
8,605
-3,448
| -29% | -$265K | ﹤0.01% | 2607 |
|
2020
Q3 | $901K | Buy |
12,053
+726
| +6% | +$54.3K | ﹤0.01% | 2230 |
|
2020
Q2 | $713K | Buy |
11,327
+32
| +0.3% | +$2.01K | ﹤0.01% | 2356 |
|
2020
Q1 | $474K | Sell |
11,295
-440
| -4% | -$18.5K | ﹤0.01% | 2449 |
|
2019
Q4 | $533K | Sell |
11,735
-4,048
| -26% | -$184K | ﹤0.01% | 2671 |
|
2019
Q3 | $722K | Sell |
15,783
-279
| -2% | -$12.8K | ﹤0.01% | 2392 |
|
2019
Q2 | $942K | Sell |
16,062
-1,371
| -8% | -$80.4K | ﹤0.01% | 2247 |
|
2019
Q1 | $782K | Buy |
+17,433
| New | +$782K | ﹤0.01% | 2345 |
|
2017
Q2 | – | Sell |
-1,160
| Closed | -$17K | – | 3275 |
|
2017
Q1 | $17K | Buy |
+1,160
| New | +$17K | ﹤0.01% | 3107 |
|
2014
Q2 | – | Sell |
-3,205
| Closed | -$202K | – | 2228 |
|
2014
Q1 | $202K | Buy |
+3,205
| New | +$202K | ﹤0.01% | 2060 |
|